Categories: NewsProsthetic

PROTEOR Acquires Filament Innovations

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Acquisition Will Strengthen PROTEOR’s Expanding Digital Portfolio

DIJON, France, Feb. 5, 2025 /PRNewswire/ — PROTEOR today announced the acquisition of Filament Innovations, a leader in the design and manufacture of 3D printing solutions for the Orthotics & Prosthetics (O&P) industry. With this pivotal acquisition, PROTEOR further strengthens & expands its portfolio of Digital Solutions, which now includes scanning, rectification software, and 3D printing capabilities. 

“By acquiring Filament Innovations, PROTEOR is able to offer the highest quality 3D printers in the industry while further elevating and streamlining the overall digital experience for our customers,” said Edouard Archambeaud, CEO of PROTEOR. “We are very excited to welcome Filament Innovations into the PROTEOR family.”

Filament Innovations is an industry leader in two key areas:

  • Leadership in 3D Printer Technology. Filament Innovations is at the forefront of 3D Printing, mastering extrusion and high-speed printing of carbon-filled materials. Filament’s premier printer – the ICARUS 3D Printer – has a well-earned reputation of excellence, offering clinicians advanced printing applications. One such application is the production of definitive sockets, a major advancement within O&P.
  • Leadership in Printing Filament. Filament Innovations offers a variety of filament options, including pellets and filament of PETG, TPU, and CPX-KyronMAX. CPX-KyronMAX filament, a joint development effort, has passed internal standards to be classified as a Definitive socket – a first for the O&P industry. When combined with the ICARUS 3D Printer, this allows for Definitive prosthetic sockets to be printed in less than two hours.

“We are committed to providing our customers with the most advanced 3D printing technologies available today – including the highest-quality filament available,” said Mike Gorski, CEO and founder of Filament Innovations. “The PROTEOR acquisition will enable our technologies and materials to reach more people in more places around the world. In this industry, I have learned a lot from our customers on how this process needs to be streamlined for widespread digital adoption. PROTEOR, especially with the ORTEN software, will soon allow us to connect all of our digital devices allowing for a streamlined digital workflow process, a critical process that is missing from the industry.” 

To learn more about the PROTEOR Digital Portfolio, contact your PROTEOR representative or visit us.proteor.com.

THE PROTEOR PROMISE 

PROTEOR is a leading prosthetic and orthotic device company committed to collaborating with clinicians to spark real-world innovations. We are inspired by the people who use our products. Seeing their everyday achievements motivate us to make more things possible. Our extensive portfolio includes technological breakthroughs that allow the utmost mobility, maneuverability, adaptability, and durability. PROTEOR’s process for developing advancements and community support is based on a collaborative approach with clinicians and the people they care for. When we all work together, it’s amazing how much patients can achieve. #HumanFirst

Media Contact:

Alexandra Houiste, Global Corporate Communications Manager
PROTEOR
+33 (0)6 40 73 99 97
Alexandra.Houiste@Proteor.com

Eric Ferris, Vice President – Global Marketing & Product Management
PROTEOR
+1.855.450.7300
Eric.Ferris@proteor.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/proteor-acquires-filament-innovations-302369346.html

SOURCE PROTEOR

Staff

Recent Posts

GenomOncology Partners with Chronetyx Laboratories to Accelerate Cancer Care Through Comprehensive Genomic Profiling

CLEVELAND, March 31, 2025 /PRNewswire/ -- GenomOncology, a precision medicine software company, today announced a…

3 hours ago

InventHelp Inventor Develops Improvement for Portable Oxygen Concentrators (SBT-1981)

PITTSBURGH, March 31, 2025 /PRNewswire/ -- "I thought there could be a way to improve…

3 hours ago

Petszel Surpasses 500,000 Annualized Pet Adoptions, Announces Upcoming Launch of Teleadvice for Adopters

FRISCO, Texas, March 31, 2025 /PRNewswire/ -- Petszel, the leading platform for post-adoption support, has…

3 hours ago

U.S. Ambulatory EHR Market to Reach $3.97 Billion by 2031, Growing at 5.8% CAGR from 2024 — Exclusive Report by Meticulous Research®

Market Growth Driven by Government Initiatives, Technological Advancements, and Increasing Patient Preference for Outpatient Care…

3 hours ago

TrampolineAI Launches AI-Powered Healthcare Contact Center Platform to Transform Member and Agent Experiences

HealthCheck360 Deploys TrampolineAI, Seeing Immediate Impact SAN FRANCISCO, March 31, 2025 /PRNewswire/ -- TrampolineAI, an AI-powered…

3 hours ago

Alleva Appoints Vivek Narayanaswamy as Chief Technology Officer to Drive Innovation in Behavioral Health

LAGUNA NIGUEL, Calif., March 31, 2025 /PRNewswire/ -- Alleva, a leading provider of behavioral health…

3 hours ago